1,25-Dihydroxyvitamin D induces the glutamate transporter SLC1A1 and alters glutamate handling in non-transformed mammary cells

被引:8
作者
Beaudin, Sarah [1 ,2 ]
Welsh, JoEllen [2 ,3 ]
机构
[1] SUNY Albany, Dept Biomed Sci, Rensselaer, NY 12144 USA
[2] SUNY Albany, Canc Res Ctr, 1 Discovery Dr Suite 304D, Rensselaer, NY 12144 USA
[3] SUNY Albany, Dept Environm Hlth Sci, Rensselaer, NY 12144 USA
关键词
Mammary cells; Glutamate; Glutamine; Vitamin D; Glutathione; RELEASE; NEURODEGENERATION; MODULATION; GENE;
D O I
10.1016/j.mce.2016.01.011
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
Genomic profiling of immortalized human mammary epithelial (hTERT-HME1) cells identified several metabolic genes, including the membrane glutamate transporter, SLC1A1, as 1,25-dihydroxyvitamin D-3 (1,25D) regulated. In these studies we have surveyed the effects of 1,25D on known glutamate transporters and evaluated its impact on cellular glutamate handling. We confirm that expression of SLC1A1 and all of its known transcript variants are significantly upregulated in hTERT-HME1 cells following 1,25D treatment. Expression of the full-length cognate protein, EAAT3, is correspondingly increased in 1,25D treated hTERT-HME1 cells. Under the same conditions, the expression of two other glutamate transporters - SLCIA6 (EAAT4) and SLCIA2 (EAAT2 or GLT-1) - is enhanced by 1,25D while that of SLCIA3 (EAAT1 or GLAST) and SLC7A11 (xCT) is decreased. Glutamate is not essential for growth of hTERT-HME1 cells, and supplemental glutamate (up to 0.5 mM) does not abrogate the growth inhibitory effects of 1,25D. These data suggest that extracellular glutamate is not a major contributor to cellular energy metabolism in hTERT-HME1 cells under basal conditions and that the growth inhibitory effects of 1,25D are not secondary to its effects on glutamate handling. Instead, the effects of 1,25D on glutamate transporters translated to a decrease in cellular glutamate concentration and an increase in media glutamate concentration, suggesting that one or more of these transporters functions to export glutamate in response to 1,25D exposure. The reduced cellular glutamate concentration may also reflect its incorporation into the cellular glutathione (GSH) pool, which is increased upon 1,25D treatment. In support of this concept, the expression of GCLC (which codes for the rate-limiting enzyme in GSH synthesis) and genes which generate reducing equivalents in the form of NADPH (ie, G6PD, PGD, IDH2) are elevated in 1,25D-treated cells. Taken together, these data identify 1,25D as a physiological regulator of multiple membrane glutamate transporters that impacts on overall cellular glutamate handling. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:34 / 41
页数:8
相关论文
共 33 条
[1]
Regulation of the glutamate transporter EAAT3 by mammalian target of rapamycin mTOR [J].
Almilaji, Ahmad ;
Pakladok, Tatsiana ;
Guo, Anne ;
Munoz, Carlos ;
Foeller, Michael ;
Lang, Florian .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 421 (02) :159-163
[2]
Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse [J].
Aoyama, K ;
Suh, SW ;
Hamby, AM ;
Liu, JL ;
Chan, WY ;
Chen, YM ;
Swanson, RA .
NATURE NEUROSCIENCE, 2006, 9 (01) :119-126
[3]
Banda M., 2015, PLOS ONE, V9
[4]
Comparative regulation of gene expression by 1,25-dihydroxyvitamin D3 in cells derived from normal mammary tissue and breast cancer [J].
Beaudin, Sarah G. ;
Robilotto, Samantha ;
Welsh, JoEllen .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2015, 148 :96-102
[5]
EMT-induced metabolite signature identifies poor clinical outcome [J].
Bhowmik, Salil Kumar ;
Ramirez-Pena, Esmeralda ;
Arnold, James Michael ;
Putluri, Vasanta ;
Sphyris, Nathalie ;
Michailidis, George ;
Putluri, Nagireddy ;
Ambs, Stefan ;
Sreekumar, Arun ;
Mani, Sendurai A. .
ONCOTARGET, 2015, 6 (40) :42651-42660
[6]
C6 glioma cells differentiated by retinoic acid overexpress the glutamate transporter excitatory amino acid carrier 1 (eaac1) [J].
Bianchi, M. G. ;
Gazzola, G. C. ;
Tognazzi, L. ;
Bussolati, O. .
NEUROSCIENCE, 2008, 151 (04) :1042-1052
[7]
Modulation of non-vesicular glutamate release by pH [J].
Billups, B ;
Attwell, D .
NATURE, 1996, 379 (6561) :171-174
[8]
Glutamate enrichment as new diagnostic opportunity in breast cancer [J].
Budczies, Jan ;
Pfitzner, Berit M. ;
Gyoerffy, Balazs ;
Winzer, Klaus-Juergen ;
Radke, Cornelia ;
Dietel, Manfred ;
Fiehn, Oliver ;
Denkert, Carsten .
INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (07) :1619-1628
[9]
Mitochondrial localization and structure-based phosphate activation mechanism of Glutaminase C with implications for cancer metabolism [J].
Cassago, Alexandre ;
Ferreira, Amanda P. S. ;
Ferreira, Igor M. ;
Fornezari, Camila ;
Gomes, Emerson R. M. ;
Greene, Kai Su ;
Pereira, Humberto M. ;
Garratt, Richard C. ;
Dias, Sandra M. G. ;
Ambrosio, Andre L. B. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (04) :1092-1097
[10]
Glutamatergic dysfunction in OCD [J].
Chakrabarty, K ;
Bhattacharyya, S ;
Christopher, R ;
Khanna, S .
NEUROPSYCHOPHARMACOLOGY, 2005, 30 (09) :1735-1740